Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050588

CEO sold 10,395 shares at $9.51 ($98,856)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PIMSTONE SIMON N. CEO 2019-09-20 Sale −10,395 $9.51 $98,856 258,122 D: show line 1 in the form
Open-market sales · 10,395 sh · avg $9.51 · $98,856
Loading xslF345X03/doc4.xml…